PAPI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 3.884
AS - Asia 3.117
EU - Europa 2.994
AF - Africa 272
SA - Sud America 170
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.447
Nazione #
US - Stati Uniti d'America 3.847
VN - Vietnam 963
SG - Singapore 785
CN - Cina 760
IT - Italia 638
GB - Regno Unito 637
DE - Germania 329
SE - Svezia 290
UA - Ucraina 199
FR - Francia 193
HK - Hong Kong 188
IN - India 142
RU - Federazione Russa 130
CH - Svizzera 122
BR - Brasile 111
NL - Olanda 110
IE - Irlanda 103
TG - Togo 100
CI - Costa d'Avorio 72
ZA - Sudafrica 59
FI - Finlandia 57
JP - Giappone 52
EE - Estonia 46
BG - Bulgaria 34
JO - Giordania 31
CA - Canada 27
PH - Filippine 25
TH - Thailandia 24
BE - Belgio 23
KR - Corea 21
PL - Polonia 21
AR - Argentina 20
BD - Bangladesh 17
SC - Seychelles 17
TW - Taiwan 16
ID - Indonesia 14
IQ - Iraq 14
IR - Iran 14
NG - Nigeria 12
CL - Cile 11
GR - Grecia 11
EC - Ecuador 10
HR - Croazia 10
ES - Italia 9
PK - Pakistan 9
SA - Arabia Saudita 9
EG - Egitto 7
RO - Romania 7
TR - Turchia 7
AT - Austria 6
AU - Australia 6
CO - Colombia 6
UZ - Uzbekistan 6
HU - Ungheria 5
MX - Messico 5
PE - Perù 5
CZ - Repubblica Ceca 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
KZ - Kazakistan 2
NP - Nepal 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GY - Guiana 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.447
Città #
Southend 540
Singapore 535
Ashburn 399
Chandler 363
Fairfield 304
Dong Ket 234
San Jose 216
Santa Clara 215
Hong Kong 173
Hanoi 165
Wilmington 164
Ho Chi Minh City 149
Woodbridge 145
Houston 144
Jacksonville 136
Ann Arbor 134
Princeton 133
Bologna 124
Bern 114
Cambridge 112
Seattle 110
Beijing 106
Dublin 102
Lomé 100
Boardman 74
Abidjan 72
Lauterbourg 60
Westminster 59
Padova 56
Helsinki 54
Nanjing 51
Rome 50
Hefei 48
Los Angeles 43
Tokyo 42
Dallas 39
New York 39
Berlin 38
Haiphong 38
Sofia 34
Buffalo 33
Amman 31
Da Nang 30
Changsha 29
Dearborn 29
Guangzhou 28
Milan 27
Frankfurt am Main 26
Turin 26
Jinan 24
Medford 24
Shenyang 24
Saint Petersburg 23
Brussels 22
Mülheim 22
Florence 20
Shanghai 20
Hebei 19
Nanchang 18
Zhengzhou 17
Jiaxing 16
San Diego 16
Munich 15
Redmond 15
São Paulo 15
Redwood City 14
Tianjin 14
Verona 14
Falkenstein 13
Hangzhou 13
Yubileyny 13
Abeokuta 12
Johannesburg 12
Mahé 12
Phoenix 12
Toronto 12
Brooklyn 11
Mountain View 11
The Dalles 11
Warsaw 11
Council Bluffs 10
Des Moines 10
Fremont 10
Olalla 10
Redondo Beach 10
Seoul 10
Amsterdam 9
Ardabil 9
Bangkok 9
Düsseldorf 9
Quận Ba 9
Wuhan 9
Chicago 8
Fuzhou 8
Jakarta 8
Kunming 8
Nuremberg 8
San Francisco 8
Taizhou 8
Wroclaw 8
Totale 6.646
Nome #
Effetti co-cancerogeni della vitamina E a livello prostatico 411
Co-carcinogenic effects of vitamin E in prostate 271
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 248
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro 248
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 246
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells 236
Co-mutagenic and pro-oxidant effects of Vitamin E promotes DNA damage and cell transformation in prostate 231
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion 228
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 224
Carbonic anhydrase 9 mRNA/microRNA34a interplay in hypoxic human mammospheres 222
A Ligand of Retinoid X Receptor Overcome Multidrug Resistance in Human Colon Carcinoma LoVomdr Cell Line 213
Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells 208
Cytotoxic and Antioxidant Activity of 4-Methylthio-3-butenyl Isothiocyanate from Raphanus sativus L. (Kaiware Daikon) Sprouts 205
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. 204
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. 202
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 198
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 196
PPARγ and RXR Ligands Disrupt the Inflammatory Cross-talk in the Hypoxic Breast Cancer Stem Cells Niche. 195
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator activated receptor-gamma 191
Kaiware Daikon (Raphanus sativus, L.) Extract: a Naturally Multipotent Chemopreventive Agent 188
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line 188
Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue 187
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 187
Nuclear receptors agonists exert opposing effects on the inflammation-dependent survival of breast cancer stem cells. 182
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines 179
ANTITUMORAL EFFICACY OF RETINOIDS ON HUMAN MULTIDRUG RESISTANT COLON CARCINOMA (LOVO MDR) AND LEUKEMIA (HL60- MDR) CELL LINES 177
Antitumoral effect of retinoids on two human bladder cancer cell lines 174
ANTITUMORAL EFFECT OF RETINOIDS: A COMPARISON BETWEEN ALL TRANS RETINOIC ACID AND IIF, A SPECIFIC LIGAND OF RXR 173
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator-activated receptor gamma 163
6-OH-11-hydroxyphenantrene and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 163
Antitumoral effect of retinoids on two human bladder cancer cell lines 159
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. 159
Search for multidrug resistance modulators: effects of retinoids in human colon carcinoma cells 156
Antitumoral efficacy of retinoids on human multidrug resistance colon carcinoma (LoVoMDR) and leukemia (HL-60 MDR) cell lines 156
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 155
Epigenetic Modifiers as Anticancer Drugs: Effectiveness of Valproic Acid in Neural Crest-derived Tumor Cells 155
Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in U87MG human glioblastoma cell line, 155
Is somatostatin a physiological regulator of human trophoblast functions? 152
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells 147
Polymeric Micelles Using Pseudo-Amphiphilic Block Copolymers 146
Role of nuclear receptors in breast cancer stem cells 145
Cytotoxic and antioxidant activity of freeze-dried extract from Japanese daikon sprout (Raphanus sativus, L) 143
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells. 143
Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue 142
Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines. 141
PPAR-alpha nuclear receptor/ApoE axis: a new target of Breast Cancer Stem Cells 141
Growth inhibition and proapototic activity induction by the retinoid IIF and valproic acid on HT-29 colon cancer cell line 139
EFFECTS OF RETINOIDS ON DRUG SENSITIVE AND MULTIDRUG RESISTANT HUMAN COLON CARCINOMA CELLS 138
PPARγ and retinoid X receptor ligands are potent antitumoral agents in the glioblastoma cell line U87MG 136
Polymeric micelles using pseudo-amphiphilic block copolymers and their cellular uptake 136
Inhibitory effect of the retinoid IIF on cancer cell invasion mediated by the down regulation of matrix metalloproteinases expression in human glioblastoma cells 131
Trattamento di cellule MCF-7 resistenti al tamoxifene con (-)-epigallocatechina-3-gallato 129
Retinoid Receptor Ligands are Potent Anti-inflammatory Agents in Breast Cancer Stem Cells Model 124
PPARgamma and RXRligans act sinergistically as potent antineoplastic agents in vitro and in vivo glioma models 120
Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein 118
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 116
The rexinoid 6-OH-11-O-hydroxyphenantrene induces apoptosis of human osteosarcoma and mesenchymal stem cells. 111
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. 111
Retinoids Hamper Inflammation in Normal and Cancer Epithelial Cell Lines. 106
null 91
XXI Convegno Annuale ABCD (Stress cellulare: sopravvivenza ed apoptosi), Atti convegno 86
null 79
Totale 10.604
Categoria #
all - tutte 25.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 0 0 0 0 0 56 359
2021/20221.194 102 72 56 80 84 62 25 82 28 115 251 237
2022/20231.575 137 246 85 179 87 112 31 81 279 45 122 171
2023/2024435 22 60 19 51 37 90 32 36 7 32 31 18
2024/20251.441 67 202 135 122 287 83 71 40 7 130 14 283
2025/20262.892 250 181 230 174 401 177 271 140 792 240 36 0
Totale 10.604